ADMA Biologics Inc (NASDAQ:ADMA)

4.91
Delayed Data
As of Jun 22
 +0.05 / +1.03%
Today’s Change
2.01
Today|||52-Week Range
5.70
+52.96%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$238.4M

Company Description

ADMA Biologics, Inc. is a biopharmaceutical company. It develops, manufactures, and intends to commercialize in human plasma and plasma-derived therapeutics. It operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment comprises of the immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Hackensack, NJ.

Contact Information

ADMA Biologics, Inc.
465 State Route 17
Ramsey New Jersey 07446-2012
P:(201) 478-5552
Investor Relations:

Employees

Shareholders

Other institutional35.57%
Individual stakeholders32.08%
Mutual fund holders3.75%

Top Executives

Adam S. GrossmanPresident, Chief Executive Officer & Director
Brian LenzCFO, Principal Accounting Officer & VP
James MondChief Scientific Officer & Chief Medical Officer
Theresa GwaltneySenior Director-Supply Chain Operations
James HauertSenior Vice President-Commercialization & Strategy